Eden Hands Keys To CDMO Unit Over To Bora Pharmaceuticals
Taiwanese Biologics Developer Will Maintain Relationship With Spun-Out Unit
Eden Biologics has sold its CDMO business to Bora Pharmaceuticals’ recently-established biologics CDMO platform Bora Biologics. The firm appears keen to maintain a working relationship with its former unit following the sale.
